BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18704226)

  • 41. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
    Hung MS; Xu Z; Lin YC; Mao JH; Yang CT; Chang PJ; Jablons DM; You L
    BMC Cancer; 2009 May; 9():135. PubMed ID: 19419583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing glioblastoma cells.
    Joughin BA; Naegle KM; Huang PH; Yaffe MB; Lauffenburger DA; White FM
    Mol Biosyst; 2009 Jan; 5(1):59-67. PubMed ID: 19081932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein kinase CK2: a newcomer in the 'druggable kinome'.
    Pagano MA; Cesaro L; Meggio F; Pinna LA
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1303-6. PubMed ID: 17073807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of CK2 constitutive activity in cancer cells.
    Ruzzene M; Di Maira G; Tosoni K; Pinna LA
    Methods Enzymol; 2010; 484():495-514. PubMed ID: 21036247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.
    Cozza G; Bonvini P; Zorzi E; Poletto G; Pagano MA; Sarno S; Donella-Deana A; Zagotto G; Rosolen A; Pinna LA; Meggio F; Moro S
    J Med Chem; 2006 Apr; 49(8):2363-6. PubMed ID: 16610779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein kinase CK2 as a druggable target.
    Sarno S; Pinna LA
    Mol Biosyst; 2008 Sep; 4(9):889-94. PubMed ID: 18704226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Casein Kinase II: an attractive target for anti-cancer drug design.
    Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
    Prudent R; Cochet C
    Chem Biol; 2009 Feb; 16(2):112-20. PubMed ID: 19246001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ATP site-directed inhibitors of protein kinase CK2: an update.
    Sarno S; Papinutto E; Franchin C; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Orzeszko A; Zanotti G; Battistutta R; Pinna LA
    Curr Top Med Chem; 2011; 11(11):1340-51. PubMed ID: 21513497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular regulators of protein kinase CK2.
    Montenarh M
    Cell Tissue Res; 2010 Nov; 342(2):139-46. PubMed ID: 20976471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addiction to protein kinase CK2: a common denominator of diverse cancer cells?
    Ruzzene M; Pinna LA
    Biochim Biophys Acta; 2010 Mar; 1804(3):499-504. PubMed ID: 19665589
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.